Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Prognostic Markers in Glioblastoma Patients Treated with Temozolomide

Author:McMillan, Nadia   Zhang, Shuodan   McGuinness, Matthew   Trudeau, Stephen   Uhlmann, Erik   

Session Name:P13: Neuro-oncology: Prognosis and Survival in Brain Tumors  

Topic:Neuro-oncology  

Program Number:P13.002  

Author Institution:Beth Israel Deaconess Medical Center, Boston, MA  

Safety and Efficacy of Concomitant Erenumab and INP104 Use From the Phase 3 STOP 301 Study in Migraine Patients

Author:Ahmed, Zubair   Vann, Robert   Fitzpatrick, Christopher   Ray, Sutapa   Shrewsbury, Stephen   Aurora, Sheena   

Session Name:P13: Headache: Therapeutics 1  

Topic:Headache  

Program Number:P13.002  

Author Institution:Cleveland Clinic, Cleveland, OH  Impel Pharmaceuticals, Seattle, WA  Impel Pharmaceuticals, Fallbrook, CA  

A Case of Mononeuopathy Multiplex in the Setting of Durvalumab Therapy

Author:Scurfield, Abby   Kelly, Amanda   Desai, Ninad   Dhanjal, Sandhya   

Session Name:P13: Neuromuscular Disease: Peripheral Neuropathy 3  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P13.002  

Author Institution:Frank H. Netter School of Medicine, New Haven, CT  Frank H. Netter School of Medicine, Shelton, CT  St. Vincent's Medical Center, Bridgeport, CT  Hartford HealthCare Medical Group Cancer Institute, Bridgeport, CT